Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs

  • Page 1 of 2 (23 items) 1 2  Last

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »